Pre-visit brief software: what your team opens before the door
Pre-visit brief software for outpatient clinics: one summary screen with labs, supplements, meds, home logs, and open follow-ups assembled before the physician walks in. For FM, GLP-1, and rural practices.
The pre-visit brief is the short screen your physician opens before the patient walks in. Not a full chart review. Not an AI diagnosis. A pre-visit summary built from what already happened between visits: texts, labs, supplements, home logs, and encounter notes. Staff walk in knowing what to ask first.
Helose is pre-visit brief software on top of patient texting from your practice number. Replies show up on the brief as they arrive. Texts run on the schedule staff set at the visit.
What lands on the brief
Typical outpatient clinics see:
- Labs: latest values, dates, deltas against prior draws, FM target ranges where configured
- Supplements and meds: active dispensary regimens, start/stop dates from your EHR
- Check-in replies: adherence scores, home BP entries, GLP-1 side-effect flags from SMS threads
- Open items: pending lab uploads, reorder confirmations, nurse callback queues
Functional medicine clinics get the longer patient portfolio view. GLP-1 and weight-loss clinics get monthly check-in context. Rural practices get home log gaps before a twelve-minute slot.
Why clinics search for this separately from texting
Google splits “pre-visit summary” and “patient texting software” even though they are the same loop. Texting collects replies. The brief shows them before the visit. A reminder tool alone leaves physicians opening the room without that context. A chart-prep dashboard alone leaves coordinators chasing replies by hand.
Helose prices for the briefing, not every login. Read why we price for the brief, not the seat.
Facts, not auto-interpretation
Helose shows facts (values, dates, verbatim notes) without AI clinical interpretation. See why we never auto-diagnose in the brief.
We cite public sources in the text where it matters. For operations and finance context only, not clinical, legal, or investment advice.